If the soluble form of the tumor antigen was Grp94 in complexes with IgG, then, it would be expected that by challenging patients’ PBMCs with the antigen at proper concentrations could induce the activation of immune cells followed by an inflammatory response possibly directed against the cells presenting the antigen. This evidence concerns the gene HSP90B1 and neoplasm.